Does ERTAPENEM Cause Hepatocellular injury? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Hepatocellular injury have been filed in association with ERTAPENEM (INVANZ). This represents 0.5% of all adverse event reports for ERTAPENEM.
21
Reports of Hepatocellular injury with ERTAPENEM
0.5%
of all ERTAPENEM reports
0
Deaths
16
Hospitalizations
How Dangerous Is Hepatocellular injury From ERTAPENEM?
Of the 21 reports, 16 (76.2%) required hospitalization.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Macular degeneration (776)
Off label use (372)
Product use in unapproved indication (346)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which ERTAPENEM Alternatives Have Lower Hepatocellular injury Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN